XRP Poised For ‘Brief Correction,’ But Here’s Why It Could Go To $4
With Ripple’s regulatory approval to launch its RLUSD stablecoin, anticipation is mounting about the trajectory of XRP (CRYPTO: XRP) prices following the launch. read more
Read More
Defense Stocks Face Headwinds As Trump’s DOGE Targets Spending Cuts: Goldman Sachs Downgrades General Dynamics To Sell
U.S. defense sector braces for turbulence in 2025, as Goldman downgrades General Dynamics and reiterates bearish outlook on other names. read more
Box Undervalued? Analyst Flags Overly Pessimistic Views Amid AI Monetization Push
Analyst initiates coverage on BOX with Buy rating and $40 price target, citing potential for AI monetization and expanding market share. Latest Ratings for BOX Date Firm Action From To Mar 2022 Morgan Stanley Maintains Equal-Weight Mar 2022 JP Morgan Upgrades Underweight Neutral Mar 2022 Keybanc Maintains Overweight View More Analyst Ratings for BOX View…
What’s Going On With Palisade Bio Stock On Thursday?
Palisade Bio progresses its Phase 1 study for PALI-2108, showing safety and targeted bioactivation, with topline data anticipated in early 2025. read more
Swiss Contract Service Provider Lonza Exits Capsules Business To Focus On Drug Development
Lonza unveils its “One Lonza” strategy, highlighting a new structure to streamline operations, strengthen CDMO leadership, and project 20% CER sales growth in 2025. read more
BlackRock: ‘Reasonable Range’ Of Bitcoin Allocation In Multi-Asset Portfolios Is Between 1-2% (UPDATED)
Editor’s note: the headline has been updated to more accurately reflect BlackRock’s recommended portfolio allocation. read more
Lowe’s Positioned For Growth Amid Cost Savings And Housing Recovery: JP Morgan Analyst
JP Morgan analyst maintains Buy rating for Lowe’s Companies with positive outlook for company’s financial targets and potential for growth. Latest Ratings for LOW Date Firm Action From To Feb 2022 Telsey Advisory Group Maintains Outperform Feb 2022 OTR Global Upgrades Mixed Positive Feb 2022 Gordon Haskett Upgrades Accumulate Buy View More Analyst Ratings for…